Boundless Bio Inc. (BOLD)
NASDAQ: BOLD
· Real-Time Price · USD
1.16
-0.01 (-0.85%)
At close: Aug 15, 2025, 3:59 PM
1.16
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT
Boundless Bio Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
Revenue | 1.06M | 1.06M | 1.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 875K | 1.14M | 1.09M | 1.04M | 1.01M | 745K | 719K | 711K | 722K | 722K | 485K | 246K |
Gross Profit | -51K | -316K | -262K | -1.04M | -1.01M | -745K | -719K | -711K | -722K | -722K | -485K | -246K |
Operating Income | -71.39M | -73.72M | -73.27M | -68.78M | -65.02M | -59.59M | -54.8M | -53.07M | -51.37M | -37.41M | -25.32M | -13.25M |
Interest Income | 7.06M | 8.06M | 7.89M | 7.6M | 7.13M | 6.31M | 5.28M | 3.96M | 2.48M | 916K | 521K | 224K |
Pretax Income | -64.39M | -65.69M | -65.36M | -61.06M | -57.72M | -53.15M | -49.43M | -49.07M | -49.02M | -36.62M | -24.9M | -13.13M |
Net Income | -64.39M | -65.69M | -65.36M | -61.06M | -57.72M | -53.15M | -49.43M | -49.07M | -49.02M | -36.62M | -24.9M | -13.13M |
Selling & General & Admin | 19.64M | 19.45M | 18M | 16.42M | 15.1M | 13.33M | 12.16M | 11.19M | 10.38M | 7.5M | 4.91M | 2.5M |
Research & Development | 51.76M | 54.01M | 54.74M | 51.84M | 49.4M | 46M | 42.4M | 41.64M | 40.51M | 29.43M | 20.17M | 10.51M |
Other Expenses | -613K | -613K | -264K | 64K | 139K | 150K | 91K | 56K | -19K | -30K | -3K | n/a |
Operating Expenses | 70.78M | 72.85M | 72.44M | 68.26M | 64.5M | 59.33M | 54.56M | 52.84M | 50.89M | 36.93M | 25.08M | 13.01M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 54.33M | 73.72M | 73.27M | 68.78M | 65.02M | 59.59M | 54.8M | 53.07M | 51.37M | 37.41M | 25.32M | 13.25M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 115.92K | 115.92K | 115.92K | 115.92K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 22.36M | 22.3M | 16.98M | 22.25M | 22.02M | 22.24M | 22.24M | 22.24M | 22.24M | 22.24M | 22.24M | 22.24M |
Shares Outstanding (Diluted) | 22.36M | 22.3M | 16.98M | 22.25M | 22.02M | 22.24M | 22.24M | 22.24M | 22.24M | 22.24M | 22.24M | 22.24M |
EPS (Basic) | -2.99 | -3.06 | -3.04 | -2.75 | -2.6 | -2.39 | -2.23 | -2.21 | -2.21 | -1.65 | -1.12 | -0.59 |
EPS (Diluted) | -2.99 | -3.06 | -3.04 | -2.75 | -2.6 | -2.39 | -2.23 | -2.21 | -2.21 | -1.65 | -1.12 | -0.59 |
EBITDA | -62.93M | -65M | -64.28M | -67.75M | -64.01M | -58.61M | -53.84M | -52.12M | -50.41M | -36.69M | -24.84M | -13.01M |
EBIT | -44.85M | -64.24M | -65.36M | -68.78M | -65.02M | -59.59M | -54.8M | -53.07M | -51.37M | -37.41M | -25.32M | -13.25M |
Depreciation & Amortization | 875K | 1.14M | 1.09M | 1.04M | 1.01M | 983K | 957K | 949K | 960K | 722K | 485K | 246K |